Plain-English translation of NCT04567771 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether proton therapy causes fewer side effects than a standard radiation therapy called intensity-modulated radiation therapy (IMRT) in patients who have had surgery for cervical or endometrial cancer. Both treatments use radiation to destroy any remaining cancer cells, but proton therapy may damage nearby healthy tissues less. Researchers will measure side effects, quality of life, and long-term survival in people receiving either treatment.
Radiation therapy after cancer surgery can damage healthy tissues in the pelvis, causing side effects like bowel and bladder problems. This trial aims to find out whether proton therapy, a newer type of radiation, causes fewer of these side effects while still effectively treating cancer.
You likely qualify if…
You likely don't qualify if…
You will receive either proton therapy or intensity-modulated radiation therapy as part of your standard cancer care, delivered daily over several weeks. Before treatment starts, at the end of treatment, and then at 1 month, 1 year, and 3 years after finishing radiation, you will complete brief questionnaires (10–15 minutes each) about any side effects you're experiencing and how the treatment is affecting your daily life and quality of life. A rectal balloon will be placed during each radiation session to protect nearby tissues.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
United States